跳至主要内容
临床试验/NCT01860898
NCT01860898已完成不适用

A Phase I Study of iPS Cell Generation From Patients With COPD

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2009年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
31
试验地点
1
主要终点
Feasibility

研究概览

简要总结

As part of the long-term goal of successfully implementing tissue regeneration strategies in an individualized manner for patients with thoracic diseases including, but not limited to: cystic fibrosis, pulmonary fibrosis and pulmonary hypertension, the investigators will assess the feasibility of collecting skin biopsies from patients undergoing surgery for thoracic disease, culturing skin fibroblasts from the biopsy, and reprogramming these skin fibroblasts into induced pluripotent cells.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Undergoing Thoracic Surgery at the Mayo Clinic Rochester
  • •Presence of a Thoracic Disease

排除标准

  • 未提供

研究组 & 干预措施

Skin Biopsy

Other

干预措施: Skin Biopsy (Other)

结局指标

主要结局

Feasibility

时间窗: 1 year

As part of the long-term goal of successfully implementing tissue regeneration strategies in an individualized manner for patients with thoracic diseases including, but not limited to: cystic fibrosis, pulmonary fibrosis and pulmonary hypertension, we will assess the feasibility of collecting skin biopsies from patients undergoing surgery for thoracic disease, culturing skin fibroblasts from the biopsy, and reprogramming these skin fibroblasts into induced pluripotent cells. Markers of induced pluripotent phenotype will be utilized to assess successful reprogramming.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dennis Wigle

M.D., P.h.D.

Mayo Clinic

研究点 (1)

Loading locations...

相似试验